LBM.CN - Lions Bay Mining Corp.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
0.2800
0.0000 (0.00%)
At close: 10:12AM EDT
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close0.2800
Open0.0000
Bid0.2800 x 0
Ask0.2800 x 0
Day's Range0.2800 - 0.2800
52 Week Range0.0425 - 0.3900
Volume0
Avg. Volume147,968
Market Cap6.007M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0100
Earnings DateSep 28, 2020 - Oct 02, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Newsfile

      Lions Bay Mining Announces Execution of Secured Lending Facility with BioVaxys Inc. and Production of Vaccine Candidate for Preclinical Study

      Vancouver, British Columbia--(Newsfile Corp. - June 23, 2020) - Lions Bay Mining Corp. (CSE: LBM) (the "Company" or "Lions Bay") is pleased to announce that, following the execution of a Share Exchange Agreement with BioVaxys Inc. ("BioVaxys"), the Company has executed a USD$180,000 secured lending facility with BioVaxys, the proceeds of which will be used primarily for BioVaxys' preclinical studies of BVX-0320, a novel vaccine candidate for prevention of Covid-19 (the "BVX-0320 Vaccine Candidate"). ...

    • Newsfile

      Lions Bay Announces Definitive Agreement for BioVaxys Acquisition and Concurrent Financing

      Vancouver, British Columbia--(Newsfile Corp. - June 4, 2020) - Lions Bay Mining Corp. (CSE: LBM) (the "Company" or "Lions Bay") is pleased to announce that it has executed a Share Exchange Agreement (the "Definitive Agreement") with BioVaxys Inc. (previously known as BioVaxys LLC) ("BioVaxys"), a clinical-stage immunotherapeutics company developing vaccine platforms for SARS-CoV-2 and various cancers. Under the terms of transaction, the Company will acquire all of the issued and outstanding shares of ...

    • CNW Group

      IIROC Trading Halt - LBM

      IIROC Trading Halt - LBM

    • We Think Lions Bay Mining (CSE:LBM) Can Afford To Drive Business Growth
      Simply Wall St.

      We Think Lions Bay Mining (CSE:LBM) Can Afford To Drive Business Growth

      We can readily understand why investors are attracted to unprofitable companies. Indeed, Lions Bay Mining (CSE:LBM...

    • Newsfile

      Lions Bay Mining Announces Update on Acquisition Target BioVaxys Initiating A SARS-CoV-2 Vaccine Study and Definitive Agreement

      Vancouver, British Columbia--(Newsfile Corp. - May 14, 2020) - Lions Bay Mining Corp. (CSE: LBM) (the "Company" or "Lions Bay") is pleased to announce that it has been informed that BioVaxys LLC ( "BioVaxys") is in the process of preparing to launch a preclinical study of its proprietary vaccine for SARS-CoV-2, the virus that causes Covid-19. Lions Bay recently announced entering into a non-binding letter of intent dated April 17th, 2020 (the "LOI") to ...

    • Newsfile

      Lions Bay Mining Confirms Forward Split and Record Date

      Vancouver, British Columbia--(Newsfile Corp. - April 27, 2020) -  Lions Bay Mining Corp. (CSE: LBM) the "Company" or "Lions Bay") confirms the Record Date (the "Record Date") of April 29th, 2020 for the upcoming two-for-one (2:1) stock split of the Company's common shares. Shareholders as of the Record Date will receive two new common shares for every one common share held (the "Stock Split"). The Company will use the "push-out" method to issue the additional ...

    • Newsfile

      Lions Bay Mining Announces Non-Binding LOI to Acquire BioVaxys LLC, a Clinical Stage Biopharma Company Developing Immunotherapeutic Vaccines for Life-threatening Viral Infections and Cancers

      Vancouver, British Columbia--(Newsfile Corp. - April 20, 2020) -  Lions Bay Mining Corp. (CSE: LBM) (the "Company" or "Lions Bay") is pleased to announce it has entered into a non-binding letter of intent dated April 17th, 2020 (the "LOI") to acquire BioVaxys LLC ("BioVaxys") a private Delaware corporation (the "Proposed Transaction").BioVaxys is a clinical stage biopharma company developing immunotherapeutic vaccines for life-threatening viral infections and various cancers. BioVaxys's vaccine technology platform is based on ...

    • Newsfile

      Lions Bay Announces Proposed Stock Split

      Vancouver, British Columbia--(Newsfile Corp. - April 17, 2020) - Lions Bay Mining Corp. (CSE: LBM) (OTC PINK: LMNGF) ("Lions Bay" or the "Company") announces that it intends to subdivide its share capital on a 1 old share for 2 new shares basis (the "Stock Split"), subject to receipt of approval by the Canadian Securities Exchange (the "CSE"). In the event the Stock Split is completed, the outstanding common shares of the Company ...